Over a decade after the complete human genome has been sequenced, functional annotation of the ~20,000 protein-coding genes remains incomplete. Thus, systematic and scalable methods for the interrogation of the biological functions of gene products are needed. In model organisms, the elucidation of protein function by genetic inactivation has been an extremely valuable approach. But the suitability of these organisms is limited for studying human pathology as many human disease genes lack orthologs in lower eukaryotes.
A major obstacle for experimental genetics in most higher organisms is that their genomes are diploid, masking the inactivation of single alleles. However, there is no fundamental biological reason dictating that a haploid genome precludes normal cellular behavior. For instance, haploid fish and amphibians have been generated, and experiments with mosaic chickens indicate that haploid cells can contribute to multiple lineages [1] [2] [3] . Furthermore, haploid embryonic stem cells from Medaka fish and mice have recently been obtained and shown to maintain pluripotency, underlining the notion that haploid cells can behave like their diploid counterparts [4] [5] [6] .
In humans, sub-diploidy is regularly observed in leukemias, and a stable near-haploid cell line (KBM7) has been subcloned from a chronic myeloid leukemia (CML) patient sample containing the BCR-ABL1 gene fusion [7] [8] [9] . In contrast to many other established human cell lines, KBM7 cells can be reprogrammed to induced pluripotent stem cells, showing that they maintain the potential to differentiate into all three germ layers 10 .
Mutagenesis of near-haploid cells with a gene-trap retrovirus has recently been used to inactivate human genes and screen for phenotypes such as proliferative defects or sensitivity to pathogen infection [11] [12] [13] [14] [15] [16] [17] [18] [19] . However, as these screens must be performed in large pools of ~100 million cells, they have been thus far limited to positive selection for mutants resistant to a toxic agent (for example, virus, bacterial toxin or drug). An arrayed collection would allow detailed investigation of single clones or focused subsets of clones, although culturing large numbers of clones simultaneously would be challenging. We initiated a large-scale effort to subclone individual gene trap-containing cells with the aim to create a library of gene mutant cell lines. We make this unique collection of human cell clones with individual loss-of-function mutations available to the scientific community via http://clones.haplogen. org/, which will empower genetics in human cells.
RESULtS

Genomic and proteomic characterization of KBm7 cells
We analyzed in detail the genetic makeup of KBM7 cells and the repertoire of expressed mRNAs and proteins. Previously, spectral karyotyping had revealed that most KBM7 subclones contain 25 chromosomes and are diploid for chromosome 8 (karyotype 25, XY, disomic for chromosome 8, containing the Philadelphia chromosomal translocation) 7, 11 . Indeed, FACS analysis showed that interphase cells contained ~1N chromosomes (Fig. 1a) . Although this near-haploid karyotype was stable over several months of culture, diploid cells occasionally emerged (Fig. 1a) , presumably through mitotic nondisjunction 20 .
To obtain a high-resolution karyotype of KBM7 cells, we performed high-density single-nucleotide polymorphism (SNP) array genotyping (Supplementary Table 1 ). Complete loss of the Y chromosome frequently occurs in KBM7 cells, and we observed this in some of the KBM7 clones that we investigated (Fig. 1b) . In agreement with a largely haploid genome, we observed single copies for >95% of all genes. In contrast, we detected SNP heterozygosity and high signal intensities for the entire chromosome 8 and a small part of the long arm of chromosome 15, indicating that genes on these chromosomes are present in two copies. This confirmed that diploidy of these genes did not arise through a duplication event but that they were retained during clonal evolution 8 .
KBM7 cells are derived from a CML patient with a Philadelphia chromosome and display hallmarks of the myelomonocytic lineage as determined by leukocyte typing (Supplementary Table 2 ). The CML origin raises the question of which additional driver mutations may have accumulated in the KBM7 genome. Furthermore, the haploidy of KBM7 cells may phenotypically unmask germ-lineencoded recessive SNPs. To address this, we sequenced the exome and whole genome at ~21× and 34× coverage, respectively, and sequenced the messenger RNAs using 100-base-pair (bp) paired-end reads (Supplementary Table 3 ). Besides the BCR-ABL1 translocation and potentially damaging point mutations in TP53 and NOTCH1, we observed none of the recurrent aberrations in myeloid malignancies. Next we analyzed the proteome using mass spectrometry (Supplementary Table 4 ). In concordance with previous studies, protein abundance correlated with mRNA levels 21 (Fig. 1c and Supplementary Table 5 ). As for other frequently used cell lines, ~75% of all Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were represented by at least 50% of their annotated proteins ( Fig. 1d and Supplementary Table 6 ). For instance, we detected the majority of proteins annotated in diverse signaling pathways (for example, insulin, VEGF, NOD and PPAR) by protein mass spectrometry, suggesting that these pathways could be studied in KBM7 cells.
We noticed increased mRNA expression of genes from the diploid chromosome 8, likely as a consequence of the increased copy number (Fig. 1e) . However, this differential expression was less pronounced at the protein level (Fig. 1f) . This suggests that post-transcriptional proteostatic mechanisms may compensate for the increased gene dosage. To allow easy and up-to-date access to the above described data sets, we created a University of California Santa Cruz (UCSC) Genome Browser hub that additionally contains information about previously mapped insertion sites (http://kbm7.genomebrowser.cemm.at/) 12 . efficient pooled screens. In addition, barcodes greatly facilitate the retrieval of single-cell clones from multiwell plates using massive parallel sequencing. Therefore, we introduced random 22-bp DNA sequences into the retroviral genetrap vector to obtain a high-complexity barcoded vector library (Fig. 2a) . We infected KBM7 cells with a multiplicity of infection <0.1 and subjected them to FACS for GFP expression. Even though the GFP transgene is promoterless, intergenic or antisense insertions can result in low GFP expression, presumably because of long terminal repeat activity or (cryptic) genomic promoter activity. As a consequence, not all GFP + clones have disrupting insertions in genes. Subsequently, we seeded cells using a limiting dilution strategy, expanded them in 96-well plates and stored them in liquid nitrogen ( Fig. 2b) . We mapped insertion sites in individual clones ( Fig. 2c and Online Methods); examples of insertion site and DNA barcode sequences are shown in Supplementary Table 7 .
Using this pipeline we mapped 23,468 clones with an equal number of unique barcodes (Fig. 3a) . Of these, 321 clones contained gene-trap insertions in a coding exon, directly disrupting the respective open reading frame. Insertions in introns are predicted to be mutagenic if the gene-trap cassette is inserted in the sense orientation. Of 11,766 intronic insertion events, ~50% (6,352) were predicted to affect expression of the respective gene. Of the 3,396 trapped genes, 67% (2,289 genes) were expressed at FPKM (fragments per kilobase of exon per million fragments mapped) >3, and 81% (2,755 genes) were expressed at FPKM >1. As expected, essential genes such as those involved in ribosome biogenesis, splicing and amino acid metabolism were under-represented among the trapped genes ( Supplementary  Fig. 1 and Supplementary Table 8) .
As retroviral vectors display an integration bias, the proportion of newly trapped genes decreases with the size of the collection. The bias we observed using our vector was very similar to that previously reported for murine leukemia virus (MLV)-based vectors 22 (Supplementary Fig. 2) . We modeled the relationship between trapped genes and mapped clones to investigate the proportion of expressed genes that can be recovered using our strategy (Supplementary Figs. 3 and 4) . From this analysis we estimate that to recover 8,000 trapped genes (>75% of the expressed genome) ~35,000 mutant clones are required, which is within reach using the current platform.
FACS analysis of 171 clones revealed that 143 clones (~84%) remained haploid after 4-6 weeks of culture. Furthermore, high-density SNP analysis of eight mutant clones revealed only few minor genetic alterations, suggesting limited genetic drift (Supplementary Table 9 ). Information on all clones is available at http://clones.haplogen.org/ and in Supplementary Table 10 .
haploid gene trap mutants resemble gene knockouts
We generated the majority of the mutant clones using a vector containing a gene-trap cassette flanked by loxP sites. For the 4,512 clones with intronic insertions and loxP sites (62%), this allows reversible gene inactivation (Fig. 3b) . Indeed, upon infection with a retrovirus expressing Cre recombinase, the gene-trap cassette was readily excised. Furthermore, protein expression was restored, albeit not fully for all examined clones ( Fig. 3c and Supplementary  Fig. 5 ). This suggests that in some instances the remaining retroviral and loxP sequences impinge on gene transcription.
To illustrate that the splice acceptor of the gene-trap cassette is efficiently used by the cellular splicing machinery and thereby disrupts the associated gene transcript, we first used a reverse trancriptase (RT)-PCR-based validation approach. We designed primers flanking the gene-trap insertion site and used them to amplify cDNA from selected clones. As expected, efficient splicing of the gene-trap into the endogenous transcript resulted in the absence of a PCR product (Fig. 3d) . However, not all clones displayed a strong reduction in the amount of PCR product (data not shown). Although in some cases this may be explained due to the technical limitations of the assay, it indicates that in a fraction of the clones the gene-trap insertion does not efficiently disrupt expression. npg For a second set of clones, we analyzed both protein expression and performed quantitative (q)RT-PCR analysis (Fig. 3e and  Supplementary Table 10) . Low mRNA levels resulted in undetectable expression at the protein level ( Fig. 3e and Supplementary  Table 11) . We conclude that gene-trapping of haploid KBM7 cells can result in near-complete gene inactivation akin to that in conventional knockouts.
Reverse genetic analysis of selected mutants
We analyzed the phenotypes of selected gene-trapped clones to illustrate their value as tools for studying gene function. Signaling through tumor necrosis factor receptor 1 (TNFR1, encoded by the TNFRSF1A gene) contributes to inflammatory diseases, and interfering with its function has revolutionized the treatment of rheumatoid arthritis 23 . A clone containing an effective disruption of TNFRSF1A would be expected to no longer respond to stimulation with TNF-α. Indeed, cells with mutant TNFRSF1A did not degrade the downstream target IκB-α upon stimulation with TNF-α ( Fig. 4a; qRT-PCR data for this clone and others used in Fig. 4 are in Supplementary Table 12 ). Consequently, these cells were almost completely impaired in their transcriptional response to TNF-α (Fig. 4b) and were resistant to TNF-α-induced apoptosis (Fig. 4c) . Thus, cells with mutant TNFRSF1A are refractory to TNF-α-induced signaling and provide a tractable tool to study TNF-mediated effects.
The cytokine TGF-β transmits signals into the cell by binding the TGF-β receptor I (TGFBR1). Subsequent heterodimerization with the TGF-β receptor II (TGFBR2) results in the downstream phosphorylation of second messengers, including the receptoractivated SMAD proteins, which instruct cellular programs involved in cell cycle, apoptosis, differentiation and immune regulation 24 . Cells with mutant TGFBR1 or TGFBR2 could not phosphorylate SMAD2 upon treatment with TGF-β (Fig. 4d) . Future studies, for instance, with gene-trapped cells reconstituted with TGF-β receptor point mutants, could be valuable for the unraveling of signaling events triggered by TGF-β.
Inactivating mutations in the gene encoding Neurofibromin 1 (NF1) cause hereditary and sporadic cancers. It is known that NF1 acts as a negative regulator of Ras by stimulating its intrinsic GTPase activity. We used the cells with mutation in NF1 from the collection to test the impact of NF1 loss on Ras signaling upon serum starvation. We detected elevated phosphorylation of the downstream effector ERK (Fig. 4e) , confirming the negative role of NF1 in the Ras-RAF-ERK pathway and illustrating that isogenic mutant KBM7 cells can be used to systematically study oncogenic signaling pathways.
Interferon gamma (IFN-γ) is a critical mediator of innate and adaptive immunity and signals by activating the JAK-STAT pathway through its cognate receptor. Access to isogenic cell lines bearing mutations in IFN-γ signaling components will allow a systematic dissection of the pathway. The collection already contains mutants for several components, including the genes IFNGR2, JAK1, JAK2, SOCS7, GRB2, SOS1, SOS2, STAT3, STAT4, PTPN6 (which encodes SHP-1) and CBLC (which encodes c-CBL). Here we used cells with mutant JAK2 to begin such an analysis. These cells displayed a severe but not complete reduction of phosphorylated STAT1 levels upon stimulation (Fig. 4f) . This suggests alternative routes of activation, most likely via the close homolog JAK1. Accordingly, the transcriptional response to IFN-γ was severely blunted in KBM7 cells with mutant JAK2 (Fig. 4g) . STAT1 activation could be restored upon Cre recombinase-mediated excision of the gene trap, confirming that the blunted signaling was caused by impaired JAK2 expression (Supplementary Fig. 6 ).
Caspase-8 is an essential effector of extrinsic apoptotic stimuli, including Fas ligand and TRAIL 25, 26 . We tested the CASP8 mutant cells in the collection and found that they were indeed completely resistant to TRAIL-induced cleavage of the effectors caspase-3 and RIP1 (Fig. 4h) , demonstrating its nonredundant role. Although cells with mutant CASP8 were resistant to TRAIL-induced apoptosis, they retained sensitivity to another apoptosis-inducing agent, doxorubicin (Fig. 4i) . A complete block of the caspase-8-mediated cell death pathway may allow future screens for genes circumventing this pathway.
ARID2 (also called BAF200) is a component of the PBAF SWI-SNF chromatin remodeling complex, and loss-of-function mutations have been found in a variety of tumors [27] [28] [29] [30] . However, the molecular function of ARID2 and its role as a tumor suppressor are poorly understood. ARID2 has been found to be required for the induction of selected interferon-response genes, including IFITM1, suggesting a role in the antiviral response 31 . Supporting this essential role, KBM7 cells with mutant ARID2 could not induce IFITM1 mRNA levels beyond basal expression in response to treatment with IFN-γ (Fig. 4j) .
Approximately 1% of eukaryotic proteins are modified with a glycosyl-phosphatidyl-inositol (GPI) moiety that anchors them to the outer leaflet of the plasma membrane 32 . Germ-line mutations in the genes that mediate GPI attachment result in a form of hemolytic anemia called Paroxysmal nocturnal hemoglobinuria. KBM7 cells express the GPI-anchored proteins CD55 and CD59, and our collection includes mutants for the GPI attachment factor genes PIGS and PIGX. When either gene was mutated, surface expression of both CD55 and CD59 was abrogated ( Fig. 4k  and Supplementary Fig. 7 ). This illustrates that KBM7 mutant cells can be used to produce proteins lacking specific posttranslational modifications, which may be useful for the production of biologicals. Together, these data illustrate that the collection of mutant KBM7 cells can be used to interrogate a wide variety of cellular processes.
dISCUSSIOn
We generated a collection of thousands of human isogenic cell lines with mutations in individual genes. Key features of the collection are: cells are of human origin, allowing genotype to phenotype relationships in a relevant model organism; cells are comprehensively characterized in terms of their molecular makeup; complete gene inactivation can be achieved; cell lines are isogenic; many insertions (in introns) are reversible via Cre recombinase-loxP technology, thus avoiding the need for reconstitution as required for RNA interference experiments or nuclease-based knockouts; and individual mutants are marked with unique DNA barcodes, enabling additional functional genetics applications.
As the mRNA transcripts of these trapped genes are dysfunctional in many clones, they can resemble conventional knockout alleles. 'Gene-trapped' mouse embryonic stem cells have been widely used for the generation of 'knockout mice' 33, 34 . However, as for mouse embryonic stem cell mutants, not every trapped gene in KBM7 cells results in the full inactivation of its associated transcripts. In some cases, the genomic context may prevent the npg efficient use of the adenovirus splice acceptor site, or alternative transcripts may mask the inactivation of a minor transcript. In other cases, a trapped gene may still yield a truncated transcript resulting in a gain of function or partially functional (i.e., hypomorphic) protein. Although these and potentially other mechanisms would yield mutant cells that do not represent full loss-of-function alleles, they may still prove valuable for the analysis of protein function. Moreover, hypomorphic alleles will be useful for enhancer or suppressor screens and thus allow the study of essential genes.
It has been well documented and we have also observed that retroviruses have a strong genomic integration bias. Indeed, their preference for the 5′ region of expressed genes has made them a preferred agent for gene trap-based mutagenesis. Although we intend to expand this mutant collection, the strongly skewed mutagenesis may stand in the way of the generation of a complete genome-wide collection. Therefore, KBM7 mutants made with other mutagens such as lentiviruses, transposons, chemicals or nucleases may aid in the construction of a complete genomewide collection. The haploid genome of KBM7 cells makes them well suited for targeted nuclease-based technologies such as transcription activator-like effector nucleases as only one allele needs to be targeted, thus greatly increasing efficiency and simplifying genotyping (data not shown).
Although the gene trap-based approach for generating mutations in human cells can be applied in diploid cells, in most cases it would only result in full gene inactivation in haploid cells, which in humans is currently restricted to KBM7 or HAP1 cells 13 . No single cell line can be expected to recapitulate all aspects of human biology, and findings in KBM7 cells require validation in independent experimental systems. However, all available evidence suggests that KBM7 cells are not less valid than other popular cell lines as a model to study well-conserved processes that may be less dependent on a particular tissue context. Thus, we propose that the most appropriate use of this collection may be the systematic annotation of gene function for basic cellular processes, such as metabolism, secretion and glycosylation as well as for common signal transduction and transcriptional processes. Careful measurement of the transcriptional landscape across many mutant KBM7 cell lines, under basal conditions or after challenge with selected stimuli will allow modeling of the logic of genetic networks with unprecedented precision and reliability. The collection presented here paves the way for a systematic and rigorous assessment of the genetic requirements of many processes under many conditions in a human cell line. codes to specify the row, the column and the plate that uniquely identify its position on a given 96-well plate.
To link barcodes with genomic insertion sites, we performed inverse PCRs of sets of 576 clones (six 96-well plates) that were all combined into one pool. Genomic DNA was isolated from cell pools and subjected to digestion with NlaIII or MseI. Digested samples were ligated and subjected to inverse PCR with the following primers: Fwd: AATGATACGGCGACCACCGAGATCT ACACATCTGATGGTTCTCTAGCTTGCC and Rev: CAAGCAG AAGACGGCATACGAGATGTTTGTACAAAAAAGCAGGC.
PCR products were subjected to paired-end sequencing using the following sequencing primers: first read (genome): CTAGCTT GCCAAACCTACAGGTGGGGTCTTTCA and second read (barcode): GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT.
The first read identified the genomic integration site of the gene trap, and the second read identified the 22-bp barcode. Each barcode was thus linked to a single genomic integration site. We estimate that the costs for the generation, mapping and isolation of individual mutant clones using this platform are between 200 and 400 Euros ($250-500) per clone. Costs are expected to decrease over time.
RT-PCRs.
To determine mRNA expression we isolated RNA and subjected it to reverse transcription. cDNA was analyzed by PCR using GoTaq Polymerase (Promega) according to manufacturer's instructions. PCR primers were custom-designed for each clone to flank the insertion site of the gene-trap cassette.
Reverse genetic analysis of selected mutant KBM7 cells. Cells stimulated with TNF-α (Peprotech) cells were lysed in Frackelton buffer (10 mM Tris/HCl pH 7.5, 50 mM NaCl, 30 mM sodium pyrophosphate, 1% Triton X-100, 50 mM NaF and protease inhibitors) and analyzed by western blotting using an IκB-α-specific antibody (C-21, dilution 1:500, Santa Cruz) and a tubulinspecific antibody (ab-7291, dilution 1:2,000, Abcam). To induce TNF-α-mediated apoptosis, cells were pretreated with 3 µg/ml cycloheximide (Sigma-Aldrich) for 1 h and subsequently stimulated with 30 ng/ml TNF-α for 24 h. Cell viability was assessed using CellTiterGlo (Promega).
To measure phospho-SMAD2 (Ser465 and Ser467, 1:500, 3108, Cell Signaling), cells were serum starved overnight and stimulated with 10 ng/ml TGF-β (Peprotech). Cell lysates were analyzed by western blotting using SMAD1/2/3 (Santa Cruz sc-7960, 1:1,000) as a loading control.
To assess the response to TRAIL, cells were stimulated with TRAIL (Peprotech) for 4 h, harvested and lysed (50 mM HEPES pH 7.4, 250 mM NaCl, 5 mM EDTA, 1% NP40, 50 mM NaF and protease inhibitors). Lysates were analyzed by western blotting using cleaved caspase-3 (9661, Cell Signaling, 1:1,000), RIP1 (610458, BD Transduction Lab, 1:1,000) and tubulin (7291, Abcam, 1:1,000) antibodies. Cell viability was assessed using CellTiter-Glo (Promega) 16 h after addition of TRAIL.
Cellular response to IFN-γ was determined by stimulating with 100 ng/ml IFN-γ (Peprotech) for the indicated time periods. Cells were washed with cold PBS and lysed in Frackelton buffer. Lysates were analyzed by western blotting using a phospho-STAT1 (Tyr701)-specific antibody (9171, dilution 1:1,000, Cell Signaling) and a tubulin-specific antibody (ab-7291, dilution 1:2,000, Abcam).
Control KBM7 or ARID2 clone was treated with IFN-γ for 24 h. Cells were then washed with PBS, and RNA was extracted using the RNeasy MinElute Cleanup Kit (Qiagen). IFITM1 expression levels were measured by qRT-PCR using the KAPA SYBR FAST ABI Prism kit (Peqlab). GAPDH housekeeping gene was used as a control.
For microarray analysis, cells were collected and total RNA was extracted using the RNeasy Mini Kit (Qiagen). RNAs were analyzed using Primeview (Affymetrix) microarrays, and the data was robust multiarray average (RMA)-normalized.
